How an individual’s sleep duration and dietary habits are associated with their likelihood of developing type 2 diabetes (T2D).
A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing
This insightful interview explores the disparities in neurological care and the innovative strategies aimed at transforming research and treatment for better, inclusive health outcomes.
People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential
How sensory nerve sprouting and mast cell activity, driven by nerve growth factor (NGF), contribute to persistent bladder pain and dysfunction in recurrent urinary tract
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a month for its entire line of inhalers that are used
Share this article Merck’s EBITDA dropped by 15.6% from €6.504bn in 2022 to €5.489bn in 2023. Credit: Merck KGaA, Darmstadt, Germany and/or its affiliates. Merck
Share this article Merus will head the early-stage research works for two programmes, with the option to expand to a third asset. Credit: aslysun /
Share this article Révérien Uwacu speaking about the five African countries that have a WHO maturity level of three, signifying high capability of overseeing clinical
The association between medical debt and population health outcomes in the US.